Sachdeva, M., Dhingra, S. and Parle, M. 2017. Dapagliflozin: a new adjunct in the treatment of Type 2 diabetes mellitus. International Journal of Basic & Clinical Pharmacology. 3, 4 (Jan. 2017), 741–747.